SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 98.72 |
| Enterprise Value ($M) | 35.90 |
| Book Value ($M) | 48.95 |
| Book Value / Share | 1.28 |
| Price / Book | 2.02 |
| NCAV ($M) | 47.72 |
| NCAV / Share | 1.25 |
| Price / NCAV | 2.07 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.31 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -0.90 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.97 |
| Current Ratio | 3.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 63.81 |
| Assets | 65.05 |
| Liabilities | 16.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Balyasny Asset Management Llc | 8.06 | ||
| 13D/A | Beigene, Ltd. | 3.17 | -90.00 | |
| 13G | Samsara BioCapital, L.P. | 6.40 | ||
| 13G | Gilead Sciences Inc | 13.90 | ||
| 13G/A | Perceptive Advisors Llc | 4.00 | -84.12 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 149,643 | 601,288 | 24.89 | |
| 36,656 | 210,698 | 17.40 | |
| 78,110 | 207,262 | 37.69 | |
| 51,757 | 281,927 | 18.36 | |
| 57,851 | 201,906 | 28.65 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LIPO – Lipella Pharmaceuticals Inc. | LIXT – Lixte Biotechnology Holdings, Inc. |
| LPCN – Lipocine Inc. | LQDA – Liquidia Corporation |
| LSTA – Lisata Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io